A Study on the Safety and Functionality of the Implantable Wireless Brain-Computer Interfaces for Motor Rehabilitation

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorShanghai StairMed Technology Co., Ltd.

About this trial

The objective of this study is to evaluate the safety and efficacy of minimally invasive, wireless brain-machine interface system (WRS) in patients with paralysis (resulting from spinal cord injuries, brainstem strokes, amyotrophic lateral sclerosis, or other motor neuron diseases causing complete or incomplete quadriplegia) or bilateral upper limb amputations. By leveraging brain-machine interface alternative technology, participants can use brain signals to control external devices (such as moving cursors, wheelchairs, robotic arms, WeChat Mini Programs, and other physical assistive devices), thereby improving their motor function and quality of life.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults aged 18-65 years;

Patients with complete or incomplete quadriplegia due to spinal cord injury, brainstem stroke, amyotrophic lateral sclerosis (ALS), or other motor neuron diseases, or those with bilateral upper limb amputations;

Normal motor cortex function confirmed by neurological assessment;

Muscle strength of bilateral or unilateral upper limbs ≤ Grade 3;

Disqualifiers

Patients with neuropsychiatric disorders or psychological impairments;

Patients with brain MRI findings showing hemorrhage, tumors, anatomical abnormalities, or distortions;

History of severe systemic diseases (e.g., cardiac, pulmonary, hepatic, renal, thyroid, gastrointestinal, or hematologic disorders), poorly controlled diabetes, or pregnancy in females;

History of infectious diseases (e.g., syphilis, HIV), severe traumatic brain injury, or major surgeries;

Trial design

Design model

Single group

Treatments tested in this trial

  • Implant

    Device

    Implantation of the device and follow-up

Treatment groups

5 Participants
are divided into 1 treatment group
Group A: Implantation of the WRS64Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Adverse events

The incidence of adverse events associated with the device or surgical procedure

Time frame
Within 6 months after implantation

Secondary outcomes

1

WRS Efficacy Assessment- Accuracy

Validation of motor function improvement through cursor control performance metrics: the accuracy of of task list (number of correct items/ number of all items), the higher the better.

Time frame
6 months after the implantation
2

WRS Efficacy Assessment- Path efficiency

Validation of motor function improvement is demonstrated through cursor control performance metrics, particularly path efficiency (the ratio of optimal to actual movement path). Higher values indicate better motor control performance.

Time frame
6 months after the implantation
3

WRS Efficacy Assessment- Time consumption

Motor function improvement is validated through cursor control performance metrics, particularly time consumption (total task completion duration). Shorter durations indicate superior motor performance.

Time frame
6 months after the implantation
4

Neurological Recovery Assessment

The International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) scale was used to evaluate overall neurological status. The higher the scale score, the better the overall neurological status.

Time frame
3, 15, 30, 90, 180 days after implantation

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: